Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) (NCT06041594)
π©Ί Plain-English Summary (8th-Grade Level)
This is a prospective, multi-center, pivotal study to demonstrate the safety and effectiveness of the Laguna Thrombectomy System for the treatment of pulmonary embolism. The Laguna Thrombectomy System is an investigational device which consists of the Laguna Clot Retrieverβ’ System and the Malibu Aspiration Catheterβ’ System. These devices are manufactured by Innova Vascular, Inc.
Who can join: Review the eligibility criteria below.
Location: Grandview Medical Center β Birmingham, Alabama
Age range: 18 Years to 85 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (21 Sites)
- Grandview Medical Center β Birmingham, Alabama
- University of Arizona β Tucson, Arizona
- University of California Irvine β Irvine, California
- Memorial Care Long Beach Medical Center β Long Beach, California
- Mission Hospital Regional Medical Center β Mission Viejo, California
- St. Joseph Hospital of Orange β Orange, California
- George Washington University β Washington D.C., District of Columbia
- Manatee Memorial Hospital β Bradenton, Florida
- Physicians Regional Medical Center β Naples, Florida
- AdventHealth Tampa β Tampa, Florida
- Rush University Medical Center β Chicago, Illinois
- Albany Medical Center β Albany, New York
- University of North Carolina at Chapel Hill β Chapel Hill, North Carolina
- OhioHealth Research Institute β Columbus, Ohio
- Turkey Creek Medical Center β Knoxville, Tennessee
- University of Texas Southwestern β Dallas, Texas
- Ankara Bilkent City Hospital β Ankara,
- Ankara Etlik City Hospital β Ankara,
- Hacettepe University Hospital β Ankara,
- Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital β Istanbul,
- Dokuz Eylul University Research and Application Hospital β Izmir,
π Contact the Study Coordinator
Phone: (949) 295-6040
Email: ss@innovavascular.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pulmonary Embolism
- Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism β Birmingham, Alabama
- Novel Ξ±2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial β Phoenix, Arizona
- Comparing Electrical Impedance Tomography to Computed Tomographic Angiography β Loveland, Colorado
- Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE β Bay Shore, New York
- Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE) β Ann Arbor, Michigan
- Pulmonary Embolism International THrOmbolysis Study-3 β Linz,
Explore by condition: All Pulmonary Embolism clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.